Effects of alpha-tocopherol treatment on newborn rat lung development and injury in hyperoxia.
The efficacy of alpha-tocopherol treatment to influence the pattern or extent of lung injury resulting during exposure of newborn rats to hyperoxia was assessed following six-day exposures to FIO2 0.21, 0.4, and greater than 0.95. Alpha-Tocopherol treatment was found incapable of preventing the developmental arrest of the lung that occurs during hyperoxic exposure, shown by assessments of wet lung weights, lung DNA, lung volumes, and the progress of secondary septal and capillary development. However alpha-tocopherol treatment was found effective in preventing the hyperoxic-induced lessening of lung compliance and in preventing the deterioration of gas exchange capacity in the lung of the hyperoxic-exposed newborn rat. These findings suggest alpha-tocopherol treatment may not be capable of preventing major alterations in lung morphology in infants with chronic lung disease may be lessened by preserving gas exchange capabilities.
D000818:Animals; D000831:Animals, Newborn / Q000502:physiology*; D001835:Body Weight / Q000187:drug effects; D004247:DNA / Q000378:metabolism; D008168:Lung / Q000187:drug effects / Q000254:growth & development* / Q000378:metabolism; D008176:Lung Volume Measurements; D009929:Organ Size; D010100:Oxygen / Q000633:toxicity*; D051381:Rats; D014810:Vitamin E / Q000627:therapeutic use*
D014810:Vitamin E; D004247:DNA; D010100:Oxygen